ReP USP - Resultado da busca

Filtros : "F. Hoffmann-La Roche" Limpar

Filtros

Artigo de periodico
Skin-sparing mastectomy for the treatment of breast cancer (2023)
Mota, B. S; Bevilacqua, J. L. B; Barrett, J; Ricci, M. D; Munhoz, A. M; Filassi, J. R; Baracat, Edmund Chada ; Riera, R
Source: Cochrane database of systematic reviews. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, MAMOPLASTIA, MASTECTOMIA, PROCEDIMENTOS CIRÚRGICOS RECONSTRUTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTA, B. S et al. Skin-sparing mastectomy for the treatment of breast cancer. Cochrane database of systematic reviews, v. 2023, n. 3, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58631. Acesso em: 28 abr. 2026.
APA
Mota, B. S., Bevilacqua, J. L. B., Barrett, J., Ricci, M. D., Munhoz, A. M., Filassi, J. R., et al. (2023). Skin-sparing mastectomy for the treatment of breast cancer. Cochrane database of systematic reviews, 2023( 3). doi:10.1002/14651858.CD010993.pub2
NLM
Mota BS, Bevilacqua JLB, Barrett J, Ricci MD, Munhoz AM, Filassi JR, Baracat EC, Riera R. Skin-sparing mastectomy for the treatment of breast cancer [Internet]. Cochrane database of systematic reviews. 2023 ; 2023( 3):[citado 2026 abr. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58631
Vancouver
Mota BS, Bevilacqua JLB, Barrett J, Ricci MD, Munhoz AM, Filassi JR, Baracat EC, Riera R. Skin-sparing mastectomy for the treatment of breast cancer [Internet]. Cochrane database of systematic reviews. 2023 ; 2023( 3):[citado 2026 abr. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58631
Artigo de periodico
Efficacy and safety of Bevacizumab-Containing therapy in newly diagnosed ovarian cancer ROSiA Single-Arm Phase 3B Study (2017)
Oza, Amit M.; Hegg, Roberto
Source: International journal of gynecological cancer. Unidade: FM
Subjects: NEOPLASIAS OVARIANAS, ANTINEOPLÁSICOS, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OZA, Amit M. e HEGG, Roberto. Efficacy and safety of Bevacizumab-Containing therapy in newly diagnosed ovarian cancer ROSiA Single-Arm Phase 3B Study. International journal of gynecological cancer, v. 27, n. 1, p. 50-58, 2017Tradução . . Disponível em: https://doi.org/10.1097/IGC.0000000000000836. Acesso em: 28 abr. 2026.
APA
Oza, A. M., & Hegg, R. (2017). Efficacy and safety of Bevacizumab-Containing therapy in newly diagnosed ovarian cancer ROSiA Single-Arm Phase 3B Study. International journal of gynecological cancer, 27( 1), 50-58. doi:10.1097/IGC.0000000000000836
NLM
Oza AM, Hegg R. Efficacy and safety of Bevacizumab-Containing therapy in newly diagnosed ovarian cancer ROSiA Single-Arm Phase 3B Study [Internet]. International journal of gynecological cancer. 2017 ; 27( 1): 50-58.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1097/IGC.0000000000000836
Vancouver
Oza AM, Hegg R. Efficacy and safety of Bevacizumab-Containing therapy in newly diagnosed ovarian cancer ROSiA Single-Arm Phase 3B Study [Internet]. International journal of gynecological cancer. 2017 ; 27( 1): 50-58.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1097/IGC.0000000000000836

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2026